Assessment of MYC/PTEN Status by Gene-Protein Assay in Grade Group 2 Prostate Biopsies

This study leveraged a gene-protein assay to assess MYC and PTEN status at prostate cancer biopsy and examined the association with adverse outcomes after surgery. MYC gain and PTEN loss were simultaneously assessed by chromogenic in situ hybridization and immunohistochemistry, respectively, using 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Salles, Daniela C., Vidotto, Thiago, Faisal, Farzana A., Tosoian, Jeffrey J., Guedes, Liana B., Muranyi, Andrea, Bai, Isaac, Singh, Shalini, Yan, Dongyao, Shanmugam, Kandavel, Lotan, Tamara L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Investigative Pathology 2021
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491088/
https://www.ncbi.nlm.nih.gov/pubmed/34062284
http://dx.doi.org/10.1016/j.jmoldx.2021.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491088/
https://www.ncbi.nlm.nih.gov/pubmed/34062284
http://dx.doi.org/10.1016/j.jmoldx.2021.05.006

Ejemplares similares